Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA5092723
Max Phase: Preclinical
Molecular Formula: C128H197N33O24
Molecular Weight: 2582.19
Molecule Type: Unknown
Associated Items:
ID: ALA5092723
Max Phase: Preclinical
Molecular Formula: C128H197N33O24
Molecular Weight: 2582.19
Molecule Type: Unknown
Associated Items:
Canonical SMILES: CC(=O)N[C@@H](Cc1cnc[nH]1)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@]1(C)CCC/C=C\CCC[C@@](C)(C(=O)N[C@@H](Cc2c[nH]c3ccccc23)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(N)=O)C(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@H](CCC(=O)O)NC1=O)C(C)C
Standard InChI: InChI=1S/C128H197N33O24/c1-75(2)64-97-120(180)160-128(9,125(185)157-100(67-81-70-140-87-40-19-17-38-85(81)87)117(177)158-105(76(3)4)122(182)150-94(47-26-34-62-134)112(172)148-93(46-25-33-61-133)111(171)147-92(45-24-32-60-132)110(170)146-91(44-23-31-59-131)109(169)145-90(43-22-30-58-130)108(168)144-89(107(135)167)42-21-29-57-129)56-28-13-11-10-12-27-55-127(8,124(184)156-96(53-54-104(165)166)114(174)152-98(116(176)151-97)66-80-49-51-84(164)52-50-80)161-121(181)101(68-82-71-141-88-41-20-18-39-86(82)88)153-119(179)103(73-162)155-113(173)95(48-35-63-139-126(136)137)149-115(175)99(65-79-36-15-14-16-37-79)154-123(183)106(77(5)6)159-118(178)102(143-78(7)163)69-83-72-138-74-142-83/h10-11,14-20,36-41,49-52,70-72,74-77,89-103,105-106,140-141,162,164H,12-13,21-35,42-48,53-69,73,129-134H2,1-9H3,(H2,135,167)(H,138,142)(H,143,163)(H,144,168)(H,145,169)(H,146,170)(H,147,171)(H,148,172)(H,149,175)(H,150,182)(H,151,176)(H,152,174)(H,153,179)(H,154,183)(H,155,173)(H,156,184)(H,157,185)(H,158,177)(H,159,178)(H,160,180)(H,161,181)(H,165,166)(H4,136,137,139)/b11-10-/t89-,90-,91-,92-,93-,94-,95-,96-,97-,98-,99-,100-,101-,102-,103-,105-,106-,127-,128-/m0/s1
Standard InChI Key: KJSNLKYJBPMGST-JBKWALOGSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 2582.19 | Molecular Weight (Monoisotopic): 2580.5209 | AlogP: | #Rotatable Bonds: |
Polar Surface Area: | Molecular Species: | HBA: | HBD: |
#RO5 Violations: | HBA (Lipinski): | HBD (Lipinski): | #RO5 Violations (Lipinski): |
CX Acidic pKa: | CX Basic pKa: | CX LogP: | CX LogD: |
Aromatic Rings: | Heavy Atoms: | QED Weighted: | Np Likeness Score: |
1. Bourbiaux K, Legrand B, Verdié P, Mallart S, Manette G, Minoletti C, Stepp JD, Prigent P, Le Bail JC, Gauzy-Lazo L, Duclos O, Martinez J, Amblard M.. (2021) Potent Lys Patch-Containing Stapled Peptides Targeting PCSK9., 64 (15.0): [PMID:34266235] [10.1021/acs.jmedchem.0c02051] |
Source(1):